Advertisement
Advertisement
IONS
Ionis Pharmaceuticals, Inc. Common Stock
48.76
USDSponsored
-2.68
-5.22%
Sep 15, 11:31 UTC -4
Open
IONS Earnings Reports
Positive Surprise Ratio
IONS beat 30 of 43 last estimates.
70%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$186.05M
/-$1.22
Implied change from Q2 26 (Revenue/ EPS)
-30.58%
/+76.81%
Implied change from Q3 25 (Revenue/ EPS)
+18.50%
/+52.50%
Ionis Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Jul 29, 2026, IONS reported earnings of -0.69 USD per share (EPS) for Q2 26, beating the estimate of -1.08 USD, resulting in a 36.66% surprise. Revenue reached 268.00 million, compared to an expected 194.48 million, with a 37.80% difference. The market reacted with a -2.28% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -1.22 USD, with revenue projected to reach 186.05 million USD, implying an increase of 76.81% EPS, and decrease of -30.58% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Apnimed, Inc. Common Stock
Report Date
Sep 08, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.34
Surprise
+34.64%
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
Galmed Pharmaceuticals Ltd.
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.18
Actual
$2.86
Surprise
+189.87%
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-Actual
-$0.54
Surprise
-
FAQ
What were Ionis Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Ionis Pharmaceuticals, Inc. Common Stock reported EPS of -$0.69, beating estimates by 36.66%, and revenue of $268.00M, 37.8% above expectations.
How did the market react to Ionis Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -2.28%, changed from $55.30 before the earnings release to $54.04 the day after.
When is Ionis Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for Ionis Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 9
analysts, Ionis Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$1.22 and revenue of $186.05M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.